Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1997 2
1998 1
2000 1
2004 1
2006 1
2007 1
2008 1
2010 2
2011 3
2012 2
2013 3
2014 4
2015 2
2017 1
2018 2
2019 1
2020 3
2021 2
2022 1
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for L?essig m[au]
Your search for L?ssig M[au] retrieved no results
Prognostic value of complement serum C3 level and glomerular C3 deposits in anti-glomerular basement membrane disease.
Caillard P, Vigneau C, Halimi JM, Hazzan M, Thervet E, Heitz M, Juillard L, Audard V, Rabant M, Hertig A, Subra JF, Vuiblet V, Guerrot D, Tamain M, Essig M, Lobbedez T, Quemeneur T, Legendre M, Ganea A, Peraldi MN, Vrtovsnik F, Daroux M, Makdassi R, Choukroun G, Titeca-Beauport D. Caillard P, et al. Among authors: essig m. Front Immunol. 2023 Jul 5;14:1190394. doi: 10.3389/fimmu.2023.1190394. eCollection 2023. Front Immunol. 2023. PMID: 37475859 Free PMC article.
Patients were categorized according to the serum C3 level (forming a low C3 (C3<1.23 g/L) and a high C3 (C31.23 g/L) groups) and positivity for C3 glomerular staining (forming the C3+ and C3- groups). ...At diagnosis, kidney involvement was characterized by a med …
Patients were categorized according to the serum C3 level (forming a low C3 (C3<1.23 g/L) and a high C3 (C31.23 g/L) groups …
Predicting Motor Outcome in Acute Intracerebral Hemorrhage.
Puig J, Blasco G, Terceño M, Daunis-I-Estadella P, Schlaug G, Hernandez-Perez M, Cuba V, Carbó G, Serena J, Essig M, Figley CR, Nael K, Leiva-Salinas C, Pedraza S, Silva Y. Puig J, et al. Among authors: essig m. AJNR Am J Neuroradiol. 2019 May;40(5):769-775. doi: 10.3174/ajnr.A6038. Epub 2019 Apr 18. AJNR Am J Neuroradiol. 2019. PMID: 31000524 Free PMC article.
[Renal urinary shear stress: a novel actor in nephropathies].
Gonzalez J, Essig M, Klein J, Caubet C, Dissard R, Bascands JL, Schanstra JP, Buffin-Meyer B. Gonzalez J, et al. Among authors: essig m. Med Sci (Paris). 2013 Mar;29(3):279-85. doi: 10.1051/medsci/2013293014. Epub 2013 Mar 27. Med Sci (Paris). 2013. PMID: 23544382 Free article. Review. French.
Estimating Extracellular Fluid Volume in Healthy Individuals: Evaluation of Existing Formulae and Development of a New Equation.
Faucon AL, Flamant M, Delanaye P, Lambert O, Essig M, Peraldi MN, Tabibzadeh N, Haymann JP, Stengel B, Geri G, Vidal-Petiot E. Faucon AL, et al. Among authors: essig m. Kidney Int Rep. 2022 Jan 26;7(4):810-822. doi: 10.1016/j.ekir.2022.01.1057. eCollection 2022 Apr. Kidney Int Rep. 2022. PMID: 35497800 Free PMC article.
RESULTS: Participants from Bichat (mean age 45.2 12.0 years, 43.0% men) and Tenon (47.8 10.3 years, 29.6% men) hospitals had a mean measured ECFV of 15.4 2.8 l and 15.1 2.1 l, respectively. Available ECFV-estimating formulae have highly variable precision and accura …
RESULTS: Participants from Bichat (mean age 45.2 12.0 years, 43.0% men) and Tenon (47.8 10.3 years, 29.6% men) hospitals had a mean measured …
[Normal aging and imaging correlations].
Schuster L, Essig M, Schröder J. Schuster L, et al. Among authors: essig m. Radiologe. 2011 Apr;51(4):266-72. doi: 10.1007/s00117-010-2093-7. Radiologe. 2011. PMID: 21461704 German.
Population pharmacokinetics of gentamicin in haemodialysis patients: modelling, simulations and recommendations.
Franck B, Monchaud C, Saint-Marcoux F, Rérolle JP, Allard J, Allot V, Marquet P, Essig M, Woillard JB. Franck B, et al. Among authors: essig m. Eur J Clin Pharmacol. 2020 Jul;76(7):947-955. doi: 10.1007/s00228-020-02867-3. Epub 2020 May 1. Eur J Clin Pharmacol. 2020. PMID: 32358683 Clinical Trial.

The POPPK model was developed in Pmetrics and 1000 time-concentration profiles were simulated for 9 doses between 2 and 10 mg/kg/day, with an inter-dose period of 24, 48 or 96 h to predict the probability of having both a serum peak > 8*MIC and a trough < 1 mg/L for

…
The POPPK model was developed in Pmetrics and 1000 time-concentration profiles were simulated for 9 doses between 2 and 10 mg/kg/day, with a …
Chronic Myelomonocytic Leukemia Patients With Lysozyme Nephropathy and Renal Infiltration Display Markers of Severe Disease.
Lafargue MC, Bobot M, Rennke HG, Essig M, Carre M, Mercadal L, Farhi J, Sakhi H, Comont T, Golbin L, Isnard P, Chemouny J, Cambier N, Laribi K, Selamet U, Riella LV, Fain O, Adès L, Fenaux P, Cohen C, Mekinian A; MINHEMON, GFM and French VEXAS group. Lafargue MC, et al. Among authors: essig m. Kidney Int Rep. 2023 Sep 7;8(12):2733-2741. doi: 10.1016/j.ekir.2023.09.005. eCollection 2023 Dec. Kidney Int Rep. 2023. PMID: 38106568 Free PMC article.
Resting-State Functional Connectivity Magnetic Resonance Imaging and Outcome After Acute Stroke.
Puig J, Blasco G, Alberich-Bayarri A, Schlaug G, Deco G, Biarnes C, Navas-Martí M, Rivero M, Gich J, Figueras J, Torres C, Daunis-I-Estadella P, Oramas-Requejo CL, Serena J, Stinear CM, Kuceyeski A, Soriano-Mas C, Thomalla G, Essig M, Figley CR, Menon B, Demchuk A, Nael K, Wintermark M, Liebeskind DS, Pedraza S. Puig J, et al. Among authors: essig m. Stroke. 2018 Oct;49(10):2353-2360. doi: 10.1161/STROKEAHA.118.021319. Stroke. 2018. PMID: 30355087 Free PMC article.
Indomethacin, amiloride, or eplerenone for treating hypokalemia in Gitelman syndrome.
Blanchard A, Vargas-Poussou R, Vallet M, Caumont-Prim A, Allard J, Desport E, Dubourg L, Monge M, Bergerot D, Baron S, Essig M, Bridoux F, Tack I, Azizi M. Blanchard A, et al. Among authors: essig m. J Am Soc Nephrol. 2015 Feb;26(2):468-75. doi: 10.1681/ASN.2014030293. Epub 2014 Jul 10. J Am Soc Nephrol. 2015. PMID: 25012174 Free PMC article. Clinical Trial.
We designed an open-label, randomized, crossover study with blind end point evaluation to compare the efficacy and safety of 6-week treatments with one time daily 75 mg slow-release indomethacin, 150 mg eplerenone, or 20 mg amiloride added to constant potassium and magnesium supp …
We designed an open-label, randomized, crossover study with blind end point evaluation to compare the efficacy and safety of 6-week treatmen …
[Recommendations for management of patients from pediatrics unit to adult unit: Transition and transfer program].
Lemoine S, Radenac J, Baudouin V, Belaiche S, Bertholet-Thomas A, Buebuyck N, Broux F, Burtey S, Champion G, Charbit M, Cochat P, De Parscau L, Delmas Y, Dunand O, Essig M, Guebre-Egziabher F, Langellier-Bellevue B, Leclerc AL, Merieau É, Moulin B, Perrin J, Rousiot D, Sartoris B, Servais A, Nagra A, Novo R. Lemoine S, et al. Among authors: essig m. Nephrol Ther. 2021 Apr;17(2):137-142. doi: 10.1016/j.nephro.2020.10.009. Epub 2021 Jan 30. Nephrol Ther. 2021. PMID: 33531259 French. No abstract available.
36 results